CAMH scientists have identified an interaction between dopamine transporter DAT and the presynaptic dopamine type 2 receptor (D2) which is thought to be an underlying cause for Attention Deficit Hyperactivity Disorder (ADHD). By characterizing this interaction, our scientists have developed a peptid.....
[Detail]
Project ID: D2016-29 IP Status: PCT patent application filed Invention Description and Novelty: “Thin” molecules offer stronger binding to PPAR and include greater lipid burning and glucose lowering properties. Applications: Dyslipidemia, obesity and type II diabetes Value propositions: • B.....
[Detail]
Membrane proteins (MP) mediate many of the cell’s fundamental processes and MPs are embedded in the cell’s membrane lipid bilayer. Currently, MPs are targets for about 60% of therapeutic drugs in use. However, MPs are very difficult to manipulate and study because they require both an aqueous enviro.....
[Detail]
| |< <- | [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] | -> >| |
